These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 21875845)

  • 1. Influence of coping style on symptom interference among adult recipients of hematopoietic stem cell transplantation.
    Schoulte JC; Lohnberg JA; Tallman B; Altmaier EM
    Oncol Nurs Forum; 2011 Sep; 38(5):582-6. PubMed ID: 21875845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of biomedical and psychosocial factors for the prediction of pain and distress in patients undergoing high-dose therapy and BMT/PBSCT.
    Schulz-Kindermann F; Hennings U; Ramm G; Zander AR; Hasenbring M
    Bone Marrow Transplant; 2002 Feb; 29(4):341-51. PubMed ID: 11896432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychological coping style versus disease extent, tumour treatment and quality of life in successfully treated head and neck squamous cell carcinoma patients.
    Aarstad AK; Aarstad HJ; Bru E; Olofsson J
    Clin Otolaryngol; 2005 Dec; 30(6):530-8. PubMed ID: 16402979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of bone loss following allogeneic and autologous hemopoietic stem cell transplantation.
    Ebeling PR; Thomas DM; Erbas B; Hopper JL; Szer J; Grigg AP
    J Bone Miner Res; 1999 Mar; 14(3):342-50. PubMed ID: 10027899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do allogeneic bone marrow transplant candidates match coping to controllability of pre-treatment stressors?
    Mah K; Khoraych M; Lipton JH; Messner HA; Khoraych G; Krawiec K; Lefebvre F; Devins GM
    Psychol Health Med; 2008 May; 13(3):337-45. PubMed ID: 18569901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered sexual health and quality of life in women prior to hematopoietic cell transplantation.
    Tierney KD; Facione N; Padilla G; Blume K; Dodd M
    Eur J Oncol Nurs; 2007 Sep; 11(4):298-308. PubMed ID: 17196431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatigue and physical activity in patients undergoing hematopoietic stem cell transplant.
    Danaher EH; Ferrans C; Verlen E; Ravandi F; van Besien K; Gelms J; Dieterle N
    Oncol Nurs Forum; 2006 May; 33(3):614-24. PubMed ID: 16676017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The coping process in adults with acute leukemia undergoing hematopoietic stem cell transplantation.
    Farsi Z; Nayeri ND; Negarandeh R
    J Nurs Res; 2012 Jun; 20(2):99-109. PubMed ID: 22592105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement in quality of life in patients with heart failure who undergo transplantation.
    Grady KL; Jalowiec A; White-Williams C
    J Heart Lung Transplant; 1996 Aug; 15(8):749-57. PubMed ID: 8878757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perceptions of Hematopoietic Stem Cell Transplantation and Coping Predict Emotional Distress During the Acute Phase After Transplantation.
    Baliousis M; Rennoldson M; Dawson DL; Mills J; das Nair R
    Oncol Nurs Forum; 2017 Jan; 44(1):96-107. PubMed ID: 27991602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft.
    Horwitz ME; Barrett AJ; Brown MR; Carter CS; Childs R; Gallin JI; Holland SM; Linton GF; Miller JA; Leitman SF; Read EJ; Malech HL
    N Engl J Med; 2001 Mar; 344(12):881-8. PubMed ID: 11259721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in quality-of-life and psychosocial adjustment among multiple myeloma patients treated with high-dose melphalan and autologous stem cell transplantation.
    Sherman AC; Simonton S; Latif U; Plante TG; Anaissie EJ
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):12-20. PubMed ID: 19135938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype.
    Aversa F; Tabilio A; Velardi A; Cunningham I; Terenzi A; Falzetti F; Ruggeri L; Barbabietola G; Aristei C; Latini P; Reisner Y; Martelli MF
    N Engl J Med; 1998 Oct; 339(17):1186-93. PubMed ID: 9780338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency.
    Buckley RH; Schiff SE; Schiff RI; Markert L; Williams LW; Roberts JL; Myers LA; Ward FE
    N Engl J Med; 1999 Feb; 340(7):508-16. PubMed ID: 10021471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term health-related quality of life, growth, and spiritual well-being after hematopoietic stem-cell transplantation.
    Andrykowski MA; Bishop MM; Hahn EA; Cella DF; Beaumont JL; Brady MJ; Horowitz MM; Sobocinski KA; Rizzo JD; Wingard JR
    J Clin Oncol; 2005 Jan; 23(3):599-608. PubMed ID: 15659507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of allogeneic T cell-depleted peripheral blood stem cell and bone marrow transplantation: effect of stem cell source on short- and long-term outcome.
    Barge RM; Brouwer RE; Beersma MF; Starrenburg CW; Zwinderman AH; Hale G; Waldmann H; den Ottolander GJ; Falkenburg JH; Willemze R; Fibbe WE
    Bone Marrow Transplant; 2001 May; 27(10):1053-8. PubMed ID: 11438820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic stem cell transplantation as treatment for heavily treated, refractory acute graft-versus-host disease after HLA-mismatched stem cell transplantation.
    Ikegame K; Yoshihara S; Taniguchi Y; Kaida K; Inoue T; Okada M; Taniguchi K; Hasei H; Tamaki H; Fujioka T; Kato R; Soma T; Ogawa H
    Exp Hematol; 2011 Aug; 39(8):880-90. PubMed ID: 21689724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health-related quality of life in patients undergoing allogeneic stem cell transplantation after reduced intensity conditioning versus myeloablative conditioning.
    Andersson I; Ahlberg K; Stockelberg D; Brune M; Persson LO
    Cancer Nurs; 2009; 32(4):325-34. PubMed ID: 19444087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of the human activity profile questionnaire in patients after allogeneic hematopoietic stem cell transplantation.
    Herzberg PY; Heussner P; Mumm FH; Horak M; Hilgendorf I; von Harsdorf S; Hemmati P; Rieger K; Greinix H; Freund M; Lee SJ; Holler E; Wolff D
    Biol Blood Marrow Transplant; 2010 Dec; 16(12):1707-17. PubMed ID: 20541028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4+CD25+ regulatory T cell depletion improves the graft-versus-tumor effect of donor lymphocytes after allogeneic hematopoietic stem cell transplantation.
    Maury S; Lemoine FM; Hicheri Y; Rosenzwajg M; Badoual C; Cheraï M; Beaumont JL; Azar N; Dhedin N; Sirvent A; Buzyn A; Rubio MT; Vigouroux S; Montagne O; Bories D; Roudot-Thoraval F; Vernant JP; Cordonnier C; Klatzmann D; Cohen JL
    Sci Transl Med; 2010 Jul; 2(41):41ra52. PubMed ID: 20650872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.